Profile data is unavailable for this security.
About the company
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It focuses on advancing science and leveraging evidence-based medicine to drive the adoption of its IB-Stim therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is a food and drug administration (FDA) cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 11-18 years old. The Company’s second product, the Rectal Expulsion Device (RED), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge defecating at lower volumes of distension.
- Revenue in USD (TTM)3.36m
- Net income in USD-8.37m
- Incorporated2022
- Employees21.00
- LocationNeuraxis Inc11611 N. Meridian St, Suite 330CARMEL 46032United StatesUSA
- Phone+1 (812) 689-0791
- Fax+1 (845) 818-3588
- Websitehttps://neuraxis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | 34.35m | -10.59m | 40.28m | 149.00 | -- | 4.47 | -- | 1.17 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| Precipio Inc | 22.80m | -1.25m | 40.98m | 54.00 | -- | 2.97 | 169.34 | 1.80 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 41.01m | 18.00 | -- | 5.75 | -- | 3.39 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| electroCore, Inc. | 29.84m | -14.16m | 43.42m | 73.00 | -- | -- | -- | 1.46 | -1.70 | -1.70 | 3.59 | -0.1405 | 1.41 | 2.63 | 29.39 | 408,698.60 | -66.70 | -65.38 | -126.40 | -87.87 | 86.04 | 80.72 | -47.46 | -159.34 | 1.33 | -- | 1.20 | -- | 57.09 | 60.15 | 36.89 | -- | -- | -- |
| Heartbeam Inc | 0.00 | -20.62m | 45.81m | 16.00 | -- | 112.50 | -- | -- | -0.6638 | -0.6638 | 0.00 | 0.0118 | 0.00 | -- | -- | 0.00 | -432.60 | -142.55 | -792.01 | -190.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.85 | -- | -- | -- |
| Spectral AI Inc | 23.17m | -16.37m | 47.57m | 78.00 | -- | -- | -- | 2.05 | -0.7206 | -0.7206 | 0.9706 | -0.301 | 1.72 | 28.41 | 12.12 | 297,025.70 | -121.66 | -- | -- | -- | 45.01 | -- | -70.64 | -- | 0.8252 | -11.99 | -- | -- | 63.83 | -- | 26.56 | -- | -- | -- |
| Nutriband Inc | 2.28m | -34.59m | 50.04m | 13.00 | -- | 6.62 | -- | 21.96 | -3.07 | -3.07 | 0.2003 | 0.621 | 0.2174 | 9.96 | 17.72 | -- | -121.91 | -66.47 | -134.92 | -78.04 | 33.50 | 37.16 | -560.85 | -340.94 | 7.35 | -- | 0.022 | -- | 2.60 | 41.99 | -91.10 | -- | -- | -- |
| Sharps Technology Inc | 2.51m | -104.37m | 51.03m | 5.00 | -- | 0.1122 | -- | 20.32 | -690.20 | -690.20 | 0.3957 | 15.68 | 0.011 | 1.81 | -- | 502,354.00 | -45.86 | -86.10 | -47.44 | -125.43 | 0.1489 | -- | -4,155.30 | -- | 3.67 | -- | 0.0173 | -- | -- | -- | 5.54 | -- | 65.50 | -- |
| Neuraxis Inc | 3.36m | -8.37m | 52.31m | 21.00 | -- | 21.28 | -- | 15.56 | -1.02 | -1.02 | 0.4059 | 0.2311 | 0.9718 | 7.94 | 41.74 | 160,111.00 | -217.93 | -- | -1,360.57 | -- | 84.34 | -- | -224.24 | -- | 1.55 | -97.22 | 0.0789 | -- | 9.18 | -- | 42.21 | -- | -- | -- |
| Alpha Pro Tech Ltd | 59.10m | 3.68m | 53.77m | 130.00 | 15.20 | 0.8535 | 11.94 | 0.9099 | 0.3415 | 0.3415 | 5.46 | 6.08 | 0.803 | 1.64 | 10.62 | 454,584.60 | 5.00 | 13.85 | 5.23 | 14.58 | 38.21 | 40.64 | 6.23 | 12.78 | 7.70 | -- | 0.00 | 0.00 | -5.54 | 4.39 | -6.21 | 5.54 | 24.04 | -- |
| CS Diagnostics Corp | 0.00 | -341.62k | 57.50m | 5.00 | -- | -- | -- | -- | -531,454.00 | -531,454.00 | -- | -- | 0.00 | -- | -- | -- | -579.61 | -1,264.84 | -- | -- | -- | -- | -- | -209,220.50 | -- | -- | -- | -- | -- | -- | 32.83 | -- | -- | -- |
| Medinotec Inc | 11.43m | 2.34m | 58.78m | 51.00 | 25.08 | 10.69 | 24.69 | 5.14 | 0.1994 | 0.1994 | 0.9734 | 0.4679 | 1.87 | 4.04 | 7.03 | 224,166.50 | 38.33 | -- | 49.87 | -- | 58.25 | -- | 20.48 | -- | 3.89 | 37.94 | 0.00008 | -- | 81.53 | -- | 633.61 | -- | -- | -- |
| Pulmonx Corp | 91.66m | -56.75m | 60.63m | 291.00 | -- | 1.01 | -- | 0.6615 | -1.41 | -1.41 | 2.28 | 1.46 | 0.5997 | 1.47 | 7.20 | 314,996.60 | -37.13 | -26.27 | -42.91 | -28.96 | 73.30 | 72.91 | -61.91 | -89.48 | 4.15 | -- | 0.3821 | -- | 22.01 | 20.78 | 7.31 | -- | 14.98 | -- |
| Outset Medical Inc | 119.48m | -81.65m | 61.59m | 354.00 | -- | 0.4852 | -- | 0.5155 | -6.81 | -6.81 | 7.91 | 6.99 | 0.4423 | 1.36 | 3.74 | -- | -30.23 | -37.90 | -35.71 | -43.82 | 39.13 | 24.03 | -68.34 | -116.47 | 5.40 | -10.15 | 0.4312 | -- | 5.09 | 19.06 | 36.20 | -- | -- | -- |
| Accuray Inc | 436.97m | -35.62m | 62.07m | 990.00 | -- | 1.16 | -- | 0.142 | -0.2982 | -0.2982 | 3.89 | 0.4713 | 0.9434 | 2.10 | 5.90 | 441,382.80 | -7.69 | -1.60 | -13.56 | -2.72 | 27.83 | 35.04 | -8.15 | -1.75 | 0.7091 | -0.3832 | 0.7178 | -- | 2.68 | 3.67 | 89.77 | -- | 2.76 | -- |
| Sensus Healthcare Inc | 35.61m | -3.01m | 63.56m | 35.00 | -- | 1.24 | -- | 1.78 | -0.1847 | -0.1847 | 2.18 | 3.11 | 0.6028 | 1.32 | 2.71 | 1,017,400.00 | -5.09 | 13.01 | -5.66 | 14.98 | 47.95 | 61.32 | -8.44 | 19.45 | 5.27 | -- | 0.00 | -- | 71.31 | 8.93 | 1,270.52 | -- | -7.18 | -- |
Data as of Feb 13 2026. Currency figures normalised to Neuraxis Inc's reporting currency: US Dollar USD
11.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AIGH Capital Management LLCas of 31 Dec 2025 | 400.00k | 3.76% |
| Money Concepts Capital Corp.as of 31 Dec 2025 | 222.61k | 2.09% |
| Parsons Capital Management, Inc.as of 31 Dec 2025 | 116.73k | 1.10% |
| District 2 Capital LPas of 09 Oct 2025 | 105.56k | 0.99% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 103.02k | 0.97% |
| Next Edge Capital Corp.as of 30 Jun 2024 | 65.00k | 0.61% |
| Geode Capital Management LLCas of 30 Sep 2025 | 50.84k | 0.48% |
| UBS Securities LLCas of 31 Dec 2025 | 48.83k | 0.46% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 42.54k | 0.40% |
| Citadel Securities LLCas of 30 Sep 2025 | 35.63k | 0.33% |
More ▼
Data from 30 Jun 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
